The New England Journal of Medicine: Case 30-2024: A 45-Year-Old Woman with Kidney Lesions and Lytic Bone Disease
Case 30-2024: A 45-Year-Old Woman with Kidney Lesions and Lytic Bone Disease
ascopubs.org: Pamidronate Reduces Skeletal Morbidity in Women With Advanced Breast Cancer and Lytic Bone Lesions: A Randomized, Placebo-Controlled Trial
Pamidronate Reduces Skeletal Morbidity in Women With Advanced Breast Cancer and Lytic Bone Lesions: A Randomized, Placebo-Controlled Trial
Nature: Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20
Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20
The American Journal of Managed Care: Case Report and Review Highlight Importance of Identifying Osteolytic Lesions in MPNs
A recent report details the first reported case of an osteolytic lesion in polycythemia vera and reviews current literature on osteolytic lesions in myeloproliferative neoplasms (MPNs) overall.
Case Report and Review Highlight Importance of Identifying Osteolytic Lesions in MPNs
If you have multiple myeloma, cancerous plasma cells divide and grow inside your bone marrow. Plasma cells are white blood cells that make antibodies. They're part of your immune system. In multiple ...
The relationship between bone marrow (BM) cytokine and chemokine levels, cytogenetic profiles and skeletal involvement in multiple myeloma (MM) patients is not yet defined. This study investigated a ...
Please provide your email address to receive an email when new articles are posted on . Denosumab appeared noninferior to zoledronic acid in time to skeletal-related events for the treatment of bone ...